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 A novel, biologically-inspired strategy was developed to improve the preservation of mesenchymal stem cells 
(MSCs). MSCs are being investigated for the treatment of cardiovascular disorders, diabetes, connective tissue 
disorders, acute lung injury, amyotrophic lateral sclerosis, kidney diseases and more.  To date, over 300 clinical 
trials involve the use of MSCs, with well over 2000 patients safely treated. Current methods of preserving MSCs 
are inadequate/ suboptimal.  Concerns over poor post thaw function have become so pervasive that it is now 
common for MSCs to be cultured for 
24-72 h prior to administration. These 
MSCs have a short shelf life (< 24 
hours), require special FDA 
permission, and the process increases 
cost and reduces access. 
 
The research described here utilizes 
an evolutionary algorithm to identify 
combinations of naturally occurring 
osmolytes that yield high cell recovery 
post thaw and optimize the 
composition of a DMSO-free, protein-
free medium for cryopreservation of 
the cells.  Additionally, we 
demonstrate that these novel 
solutions maintain MSC functionality 
when evaluated using surface 
markers, attachment, proliferation, 
actin alignment, RNA expression, 
and DNA hydroxymethlyation. 
 
MSCs were combined with algorithm dictated concentrations of different combinations of osmolytes.  Samples 
were incubated at room temperature to allow for equilibration.   Samples were frozen in a controlled rate freezer 
using a 3°C/min cooling protocol, and stored at -196°C.  Samples were thawed in a water-bath at 37°C and 
immediately enumerated using AO/PI stain on a hemocytometer to calculate recovery.  Conventional post thaw 
characterization was performed to quantify (1) attachment and proliferation; (2) alignment of the cytoskeleton; and 
(3) flow cytometry cell surface marker expression for normal MSC phenotype (CD73+, CD90+, CD105+, CD45-).  
Additional molecular analysis was performed to probe RNA expression levels for key cellular function (i.e. IDO) as 
well as epigenetic characterization of the cells to determine whether a normal methylation state of the cells has 
been maintained with the new DMSO-free solutions. 
  
The post thaw function of cells improved as the algorithm optimized solution composition for a given combination 
of osmolytes (Figure 1) suggesting that there is a ‘sweet spot’ for the solution composition.  Conventional post 
thaw characterization demonstrates that samples of MSCs frozen in DMSO-free formulations perform as well 
(proliferation, flow cytometry) or better (attachment, RNA, DNA) than DMSO frozen samples, and more closely 
mimic fresh cell behavior than MSCs cryopreserved in DMSO.  We believe that this approach can transform 
preservation of cell therapies by eliminating adverse effects of DMSO on both cells and patients, streamlining 
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Figure 1 Algorithm optimization of experimental solutions for 
attachment.  With increasing generation (advancing optimization), 
recovered cells and the fraction of those cells that attach increases. 
 
